They are relatively insensitive to cisplatin, doxorubicin, and etoposide, but upon reconstituting CASP3, the sensitivity of MCF-7 cells to these drugs could be recovered, suggesting that the loss of CASP3 expression may represent an important cell survival mechanism in the breast cancer patients [2]. The gene discussed is CASP3; the disease is breast carcinoma.